Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2023-08-03 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a communication from Neuland Laboratories Limited to stock exchanges regarding the outcome of a Board Meeting where unaudited financial results for the quarter ended June 30, 2023, were approved. It includes the unaudited standalone and consolidated financial results along with limited review reports by statutory auditors. The document references Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results disclosures. The presence of detailed financial data for the quarter and auditor's review report indicates this is a quarterly financial report rather than just an announcement or certification. The document length is substantial (15,000 characters), and it contains actual financial statements and analysis, not merely a notification or link to a report. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2023-08-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Earnings Release Classification · 95% confidence The document is a notice from Neuland Laboratories Limited announcing the schedule for the Q1 FY 2024 earnings call and the date of the results announcement (August 3, 2023). It references the upcoming earnings release but does not contain any actual financial results or detailed financial data. The document is short (2745 characters) and serves to inform about the earnings call and results release date, which fits the description of an Earnings Release announcement or Earnings Call Notice. Given the content and length, it is best classified as an Earnings Release (ER) type, as it announces the initial quarterly financial results and the related earnings call. Q1 2024
2023-07-28 English
Amendment to AOA/MOA
Governance Information Classification · 100% confidence The document is a formal disclosure letter addressed to stock exchanges (BSE and NSE) regarding the adoption of a new set of Articles of Association by the members at the 39th Annual General Meeting held on July 27, 2023. The content includes the full text of the Articles of Association, which detail the company's internal rules, board structure, and governance practices. There is no financial data or performance report, nor is it an announcement of voting results or a proxy solicitation. The document is not a report publication announcement since it contains the full Articles text, not just a notice. The Articles of Association are governance documents defining company rules and management structure, fitting the Governance Information category.
2023-07-27 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the outcome of the 39th Annual General Meeting (AGM) held on July 27, 2023. It includes a summary of proceedings, voting results, and the Scrutinizer's report as required by SEBI regulations. The content details the AGM proceedings, resolutions passed, attendance, and voting outcomes. It does not contain the full annual report or financial statements themselves but rather the results and summary of the AGM. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial and contains detailed voting results and meeting summary, not just a brief announcement or a report publication notice. Therefore, the correct classification is DVA with high confidence.
2023-07-27 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the closure of a U.S. FDA inspection at a manufacturing facility. It references a regulatory inspection and its conclusion but does not contain any financial data, detailed report, or analysis. The document is brief (1274 characters) and serves as an announcement under SEBI regulations. It does not qualify as an audit report, annual report, or any detailed financial or management report. It is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement that does not fit other specific categories.
2023-07-13 English
Board Meeting — NEULAND LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 03-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company…
Regulatory Filings
2023-07-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.